Navana Pharmaceuticals PLC
Navana Pharmaceuticals PLC, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 1992, the company has achieved notable milestones, including the development of a diverse portfolio of high-quality generic and branded medications. Specialising in therapeutic areas such as cardiology, diabetes, and infectious diseases, Navana Pharmaceuticals is recognised for its commitment to innovation and quality. Their core products, which include a range of formulations and dosage forms, are distinguished by rigorous adherence to international standards and regulatory compliance. With a strong market position, Navana Pharmaceuticals has garnered accolades for its contributions to healthcare, making it a trusted name in the industry. The company continues to expand its reach, aiming to enhance patient care both locally and globally.
DitchCarbon Score
How does Navana Pharmaceuticals PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Navana Pharmaceuticals PLC's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Navana Pharmaceuticals PLC's reported carbon emissions
Navana Pharmaceuticals PLC, headquartered in Bangladesh (BD), currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprint across various scopes of emissions. As the industry evolves, it is anticipated that Navana Pharmaceuticals will align with these trends and establish its own climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Navana Pharmaceuticals PLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
